Top Story

VIDEO: New data highlight use of ticagrelor for ad-hoc PCI

VIDEO: New data highlight use of ticagrelor for ad-hoc PCI
May 27, 2015

SAN DIEGO — In this video, Roxana Mehran, MD, professor of medicine at Icahn School of Medicine at Mount Sinai, program co-chair for the 2015 Society for Cardiovascular Angiography and Interventions Scientific Sessions and Cardiology Today’s Intervention associate medical editor, discusses the results of a trial comparing ticagrelor and clopidogrel for reduction of platelet activity in patients with ACS undergoing ad-hoc PCI.

The trial included 100 troponin-negative, low-risk patients with stabilized ACS who received a loading dose of ticagrelor (Brilinta, AstraZeneca) or clopidogrel with aspirin at the time of PCI. The researchers measured platelet activity prior to administering the loading dose, as well as at 0.5, 2 and 8 hours after and upon completion of PCI. 

In the Journals

EXACT-HF: Allopurinol fails to improve outcomes in hyperuricemic HF

May 26, 2015
At 24 weeks, xanthine oxidase inhibition with allopurinol did not improve clinical status, exercise capacity, quality of life or left ventricular ejection fraction in…
Meeting News Coverage

Analysis: LAA closure carries less per-patient cost than warfarin, aspirin

May 26, 2015
BOSTON — Left atrial appendage closure is associated with lower per-patient costs for patients with atrial fibrillation compared with treatment with warfarin or…
Meeting News Coverage

DCB successfully treats long lesions in two cohorts of patients with PAD

May 26, 2015
Results of two studies presented at EuroPCR showed that a drug-coated balloon successfully treated long lesions in the superficial femoral and popliteal arteries of…
Meeting News Coverage

Early menopause linked to lower AF risk

May 26, 2015
BOSTON — Younger age at menopause was independently associated with decreased risk for atrial fibrillation, according to new data from the Women’s Health…
More News Headlines »
CME
Examining Diverse Patient Populations and Their Response to Therapy

Examining Diverse Patient Populations and Their Response to Therapy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
Meeting News Coverage Video
VIDEO: Discussion continues on maintenance of certification in intervention cardiology

VIDEO: Discussion continues on maintenance of certification in intervention cardiology

May 24, 2015
SAN DIEGO — In this video, Charles E. Chambers, MD, FSCAI, interventional cardiologist from Penn State Hershey…
More »
CME
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan